Latest News for: Pharmaceutical sources

Edit

Worldwide Artificial Intelligence (AI) in Drug Discovery Market to reach $ 4.0 billion by 2027 ...

Eagle-Tribune 28 Jun 2022
The "Artificial Intelligence (AI) in Drug Discovery Market by Component (Software, Service), Technology (ML, DL), Application (Neurodegenerative Diseases, Immuno-Oncology, CVD), End User (Pharmaceutical & Biotechnology, CRO), Region - Global forecast to 2024" report has been added to ResearchAndMarkets.com's offering ... SOURCE.
Edit

VRCA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 5, 2022 ...

Longview News-Journal 28 Jun 2022
NEW YORK, June 28, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Verrica Pharmaceuticals, Inc ... https.//www.kleinstocklaw.com/pslra-1/verrica-pharmaceuticals-inc-loss-submission-form?id=29222&from=4. Verrica Pharmaceuticals, Inc ... SOURCE The Klein Law Firm.
Edit

Jazz Pharmaceuticals Announces Top-line Results from Phase 3 Trial Evaluating Nabiximols Oromucosal Spray in Adult ...

Ellensburg Daily Record 28 Jun 2022
DUBLIN, June 28, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq ... FDA New Drug Application submission," said Rob Iannone, M.D., M.S.C.E., executive vice president, global head of research and development at Jazz Pharmaceuticals ... About Jazz Pharmaceuticals plc Jazz Pharmaceuticals plc (Nasdaq ... SOURCE Jazz Pharmaceuticals plc.
Edit

Palleon Pharmaceuticals and Henlius Enter into Strategic Collaboration to Develop Bifunctional Sialidase Therapies

Hastings Tribune 28 Jun 2022
Palleon Pharmaceuticals, a company pioneering the field of glyco-immunology to treat cancer and inflammatory diseases, today announced a strategic collaboration with Shanghai Henlius Biotech, Inc ... About Palleon Pharmaceuticals ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220627005801/en/ ... SOURCE.
Edit

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals, Inc. -VRCA

Longview News-Journal 28 Jun 2022
NEW YORK, June 27, 2022 /PRNewswire/ --�Pomerantz LLP is investigating claims on behalf of investors of�Verrica Pharmaceuticals, Inc.�(""Verrica or the "Company")�(NASDAQ.�VRCA) ... SOURCE Pomerantz LLP.
Edit

United States Vinca Alkaloid Compounds Market Research Report 2022: Vinblastine, Vincristine, and Vindesine - Forecast ...

The Facts 28 Jun 2022
... Therapeutics, Inc.Teva Pharmaceutical Industries LimitedUman PharmaVinkemZhendong Group ... Data Source ... Pharmaceutical & Biotechnology Companies ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220628005682/en/ ... HEALTH PHARMACEUTICAL. SOURCE.
Edit

PsychoGenics Strengthens Executive Team to Boost CNS Drug Discovery and CRO Capabilities

Hastings Tribune 28 Jun 2022
David’s strong leadership, track record and extensive CNS discovery and development knowledge will significantly benefit our pharmaceutical partners and be instrumental as we advance our own drug candidate pipeline,” said Dr ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220628005306/en/ ... SOURCE.
Edit

Pharma E-commerce Market Research Report Highlights the Key Findings in the Area of Vendor Landscape, ...

Victoria Advocate 28 Jun 2022
For instance, apo-rot BV is a�company that�offers pharmaceutical products through an online portal ... Consumers can order medicines through an online platform that allows them to quickly locate the pharmaceuticals they need and place orders from a single source.Market Trend.The growing acceptance in newly regulated European states. ... SOURCE Technavio.
Edit

Iktos Announces Collaboration With Galapagos in AI For Drug Design

Eagle-Tribune 28 Jun 2022
--. About Iktos ... The use of Iktos technology enables major productivity gains in upstream pharmaceutical R&D ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220628005106/en/ ... KEYWORD ... BIOTECHNOLOGY PHARMACEUTICAL HEALTH ARTIFICIAL INTELLIGENCE MEDICAL DEVICES TECHNOLOGY CLINICAL TRIALS OTHER TECHNOLOGY. SOURCE. Iktos.
Edit

Dunad Therapeutics Appoints Industry Veteran Pearl Huang as Chief Executive Officer

Hastings Tribune 28 Jun 2022
Huang brings decades of experience spanning the biotech and pharmaceutical industries, with oversight across early drug discovery and development, translational research and alliance management ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220628005199/en/ ... SOURCE.
Edit

Academic, Industry Leaders Form OpenFold AI Research Consortium to Develop Open Source Software Tools To ...

Enid News & Eagle 28 Jun 2022
A set of leading academic and industry partners are announcing the formation of OpenFold, a non-profit artificial intelligence (AI) research consortium of organizations whose goal is to develop free and open source software tools for biology and drug discovery ... SOURCE.
Edit

Publication des résultats de l'étude de Phase 2 du fazirsiran chez les patients présentant une ...

The Joplin Globe 28 Jun 2022
Takeda ( TSE.4502/NYSE.TAK ) (“Takeda”) et Arrowhead Pharmaceuticals Inc ... À propos de Takeda Pharmaceutical Company Limited ... À propos d’Arrowhead Pharmaceuticals. Arrowhead Pharmaceuticals met au point des médicaments destinés à traiter des maladies réfractaires en neutralisant les gènes qui en sont la cause ... SOURCE.
Edit

Mountain Group Partners Completes Fundraising on $128 Million MGP Venture Fund III

Hastings Tribune 28 Jun 2022
NASHVILLE, Tenn.--(BUSINESS WIRE)--Jun 28, 2022-- ... The Firm’s technology strategy predominantly targets companies in healthcare IT and business services ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220628005191/en/. CONTACT. Jack Slaughter ... BIOTECHNOLOGY FINANCE HEALTH PROFESSIONAL SERVICES PHARMACEUTICAL. SOURCE ... PUB.
Edit

Ergebnisse der Phase-2-Studie zu Fazirsiran bei Patienten mit Alpha-1-Antitrypsin-Mangel im New England Journal of Medicine veröffentlicht

Cadillac News 28 Jun 2022
Takeda ( TSE.4502/NYSE.TAK ) („Takeda“) und Arrowhead Pharmaceuticals Inc ... Über Takeda Pharmaceutical Company Limited ... Über Arrowhead Pharmaceuticals. Arrowhead Pharmaceuticals entwickelt Medikamente, die hartnäckige Krankheiten behandeln, indem sie die Gene unterdrücken, die sie verursachen ... SOURCE. Takeda Pharmaceutical Company Limited.
Edit

XyloCor Therapeutics Achieves Target Enrollment in Phase 2 EXACT Study of XC001 Novel Gene Therapy ...

The Facts 28 Jun 2022
WAYNE, Pa.--(BUSINESS WIRE)--Jun 28, 2022-- ... Topline results from the Phase 2 study are expected in February 2023 with interim results in the second half of this year ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220628005186/en/ ... A ... HEALTH GENETICS CLINICAL TRIALS PHARMACEUTICAL CARDIOLOGY BIOTECHNOLOGY. SOURCE ... PUB.

Most Viewed

President of the Republic of Azerbaijan, Commander-in-Chief Ilham Aliyev has today visited the Central Command Post of the Ministry of Defense
Creative Commons / President.az
Bitcoin
Creative Commons / www.bitcongress.org
×